- Home
- IQ vs SGP Comparison
IQ vs SGP Comparison
Compare IQ & SGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IQ | SGP |
|---|---|---|
| Founded | 2009 | 2019 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Consumer Electronics/Video Chains | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 932.9M |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | IQ | SGP |
|---|---|---|
| Price | $1.08 | $21.07 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | $2.91 | ★ $45.00 |
| AVG Volume (30 Days) | ★ 7.0M | 51.9K |
| Earning Date | 05-18-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $0.28 | N/A |
| Revenue Next Year | $3.54 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.07 | $20.15 |
| 52 Week High | $2.76 | $30.56 |
Technical Indicators
Market Signals| Indicator | IQ | SGP |
|---|---|---|
| Relative Strength Index (RSI) | 33.98 | 36.44 |
| Support Level | $1.07 | N/A |
| Resistance Level | $1.26 | $26.29 |
| Average True Range (ATR) | 0.05 | 1.54 |
| MACD | -0.00 | -0.28 |
| Stochastic Oscillator | 20.71 | 2.59 |
Price Performance
Historical ComparisonAbout IQ iQIYI Inc.
Iqiyi is a leading streaming video-on-demand company in China that generates revenue mostly through a subscription basis. The platform also provides user-generated content to nonpaying users, monetized through ads. The company self-produces much of the subscription content and also generates revenue through content distribution, gaming, and IP licensing. Iqiyi competes directly with Tencent Video, Alibaba's Youku, ByteDance's MangoTV, and Bilibili. The company is 45% and 5% owned by Baidu and Xiaomi, respectively.
About SGP SpyGlass Pharma Inc. Common Stock
SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.